Ag Novartis is 10% Owner at Ra Pharmaceuticals, Inc. (RARX). They have made 46 open-market trades across 11 companies since 2006, most recently 2020-07-14.
CIK 0001114448
17 open-market purchases totalling $27.3M since 2006, against 29 sales. Across 7 scored buys the stock is up 15.6% at ninety days, and 10.6 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 29% | 86% |
| Avg Move | -2.8% | +1.1% | +15.6% |
| Alpha | -3.0% | -1.5% | +10.6% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 64% | 60% | 92% |
| Avg Move | -3.0% | -2.6% | -23.8% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AKUS | BUY | 2020-06-30 | 2020-07-02 | $17.00 | $2.1M | +1.6% | -4.8% | +7.1% |
| GRTX | SELL | 2020-06-15 | 2020-06-17 | $9.17 | $234K | -12.1% | -13.9% | -10.7% |
| GRTX | SELL | 2020-06-10 | 2020-06-12 | $9.37 | $242K | +3.2% | -15.7% | +3.2% |
| GRTX | BUY | 2019-11-12 | 2019-11-12 | $12.00 | $3.0M | -6.7% | -31.3% | +2.9% |
| ARPO | SELL | 2019-04-25 | 2019-04-29 | $1.03 | $1.4M | +1.0% | +2.9% | -23.3% |
| ARPO | SELL | 2019-04-22 | 2019-04-24 | $1.02 | $52K | +2.9% | +4.4% | -21.7% |
| ALRN | SELL | 2019-03-29 | 2019-04-02 | $1.86 | $236K | -7.7% | -3.8% | -62.3% |
| ARPO | SELL | 2019-03-26 | 2019-03-28 | $0.99 | $627K | +6.3% | +7.3% | -8.3% |
| ALRN | SELL | 2018-08-20 | 2018-08-22 | $2.30 | $47K | +63.2% | +35.4% | -7.1% |
| ARPO | SELL | 2018-08-20 | 2018-08-22 | $3.90 | $21K | -3.6% | -6.4% | -45.9% |
| ALRN | SELL | 2018-08-16 | 2018-08-20 | $2.10 | $37K | +16.8% | +29.4% | -16.0% |
| ALRN | SELL | 2018-08-08 | 2018-08-10 | $2.72 | $3K | -12.9% | +27.4% | -11.6% |
| ALRN | SELL | 2018-08-06 | 2018-08-08 | $3.00 | $14K | -0.8% | +35.1% | -22.5% |
| ALRN | SELL | 2018-08-02 | 2018-08-06 | $3.33 | $16K | -30.5% | +30.8% | -26.0% |
| ALRN | SELL | 2018-07-23 | 2018-07-25 | $4.25 | $133K | -18.7% | -41.7% | -34.1% |
| AGLE | SELL | 2018-05-07 | 2018-05-09 | $10.06 | $847K | -0.3% | +2.0% | -12.8% |
| ALRN | BUY | 2017-07-05 | 2017-07-05 | $15.00 | $4.0M | +5.0% | -1.5% | +17.0% |
| RARX | SELL | 2017-06-16 | 2017-06-20 | $21.32 | $1.3M | -16.3% | -32.5% | -31.1% |
| RARX | SELL | 2017-06-08 | 2017-06-12 | $22.00 | $15K | +13.7% | -14.5% | -28.6% |
| RARX | SELL | 2017-06-06 | 2017-06-08 | $22.63 | $548K | +3.8% | -21.3% | -34.8% |
| RARX | SELL | 2017-05-31 | 2017-06-02 | $23.93 | $2.2M | -7.6% | -18.9% | -35.6% |
| RARX | SELL | 2017-05-25 | 2017-05-30 | $25.14 | $135K | -15.3% | -17.9% | -37.2% |
| RARX | SELL | 2017-05-24 | 2017-05-25 | $25.01 | $873K | -11.5% | -11.3% | -39.9% |
| RARX | SELL | 2017-05-16 | 2017-05-18 | $25.90 | $2.2M | -3.7% | -12.4% | -39.2% |
| RARX | SELL | 2017-02-22 | 2017-05-02 | $20.95 | $3.5M | +1.5% | +4.5% | -35.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| AGLE | 2,268,819 | $27.2M |
| ALT | 6,275,152 | $13.8M |
| AKUS | 856,262 | $11.4M |
| ALRN | 2,079,394 | $4.4M |
| GRTX | 3,470,173 | $503K |
| IDIX | 33,185,191 | — |
| TKAI | 4,493,458 | — |
| Total | $2.3B |
Shares reported on the most recent Form 4, priced at the 2020-07-16 close. 2 holdings could not be priced and are excluded from the total.
| Scored | 25 | 25 | 25 |